TSE:MFC

Manulife Financial (MFC.TO)

57.04
+0.49 (0.87%)
as of Jun 25, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
BUY
One of his favourite stocks. Excellent franchise in Canada as well as they US with John Hancock and Asia in China and Japan. Solid earnings.
BUY
Prefers over Sun Life (SLF-T) as they have an edge on management and global diversification.
BUY
Believes it is now the #1 life insurance company in the US. Have tremendous fee revenue and growth opportunities in Asia. His favourite financial in the Canadian market. Defensive.
BUY
A very stable stock. A star Canadian financial institution. The best managed in the whole financial area in Canada. Has the best international exposure and the best earnings growth.
BUY
Good ROE. Good growth in the US through John Hancock and in Asia. Multiples are not bad.
TOP PICK
Great management. Likes their John Hancock acquisition in the US as well as their great franchises in Asia that are only going to get larger and larger. Trades at a higher ROE than the banks.
BUY
A great company. Trades at 15 X earnings. Low yield at 2%. 2nd largest life insurer in North America. The John Hancock acquisition was integrated very well. Have a great and growing franchise in Asia. Expect they will make another acquisition.
BUY
Since insurance companies tend to be cash cows, this company should have good long-term growth.
BUY
Good, solid company. Tremendous track record. Made some very important acquisitions in the US. Operates in the far east as well. Nice, long-term hold.
BUY
And interest rate sensitive company so has been under a little bit of pressure. Has outperformed the market by only falling 7/8% while the market was off 12%. About 1/3 of its earnings are Canadian, 1/3 from Asia. There are good prospects of growth from the Asian market.
HOLD
During this weak market, the share price was hanging on very well relative to the market. 2/3 days ago, people were looking for liquidity to cover their margins and this stock got hit. Very stable business and very fee based revenue.
BUY
The premier life insurance company in North America. Has the best management, the best growth prospects and a division in the far east which gives them great growth potential.
TOP PICK
Has flat lined in this bear market which historically means coming out of the bear market it will perform very well. A world leader with great growth potential. Wait for the market to settle down before buying.
HOLD
Has held up very well. If you are a trader, you may want to sell and switch into one of the banks, but if you are a long-term player, it is still a good hold.
BUY
The Canadian operations are really driving the company. Likes this company.
Showing 1,876 to 1,890 of 2,281 entries